# Lisata Therapeutics, Inc.: Form 8-K, filed Sep 14, 2022

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2022-09-14
- Accepted by EDGAR: Sep 14, 2022, 17:01 ET
- Period: 2022-09-13
- Accession: 0000320017-22-000079
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001722000079/clbs-20220913.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001722000079/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001722000079/clbs-20220913.htm

Filed Sep 14, 2022.
Source: SEC EDGAR, the filing index for accession 0000320017-22-000079. Last ingested by Listed: Nov 14, 2026, 19:21 ET. No prices; not investment advice.
